Completed suicides of citalopram users—the role of CYP genotypes and adverse drug interactions
Depression is known to be a risk factor for suicide. Currently, the most used antidepressants are selective serotonin reuptake inhibitors (SSRIs). Not all users, however, benefit from them. In such cases, treatment failure can be explained in part by genetic differences. In this study, we investigated the role of pharmacogenetic factors in citalopram-positive completed suicides (n = 349). Since citalopram is metabolized by CYP2C19 and CYP2D6 enzymes, the study population was genotyped for clinically relevant CYP2C19 and CYP2D6 polymorphisms and CYP2D6 copy number variation. To assess genetic differences between suicide cases and Finns in general, Finnish population samples (n = 855) were used as controls. Also, the role of drug interactions among suicide cases was evaluated. We found enrichment of a combined group of genetically predicted poor and ultrarapid metabolizer phenotypes (gMPs) of CYP2C19 among suicide victims compared to controls 0.356 [0.31–0.41] vs. 0.265 [0.24–0.30] (p = 0.0065). In CYP2D6 gMPs, there was no difference between cases and controls when the study population was analyzed as a whole. However, there were significantly more poor metabolizers among females who committed suicide by poisoning compared to female controls. In 8% of all drug poisoning deaths, lifetime drug-drug interaction was evaluated having a contribution to the fatal outcome. From clinical perspective, pharmacogenetic testing prior to initiation of SSRI drug could be beneficial. It may also be useful in medico-legal settings as it may elucidate obscure poisoning cases. Also, the possibility of unintentional drug interactions should be taken into account in drug poisoning deaths.
KeywordsPostmortem Suicide Citalopram CYP2C19 CYP2D6 Drug interactions
We thank Professor Emeritus Erkki Vuori for sharing his expertise.
This study is financially supported by the Doctoral Programme in Population Health, University of Helsinki, and the Medical Research Foundation of Juhani Aho.
Compliance with ethical standards
This study was approved by the Coordinating Ethics Committee of the Helsinki and Uusimaa Hospital District.
- 1.Official Statistics of Finland (2015) Number of suicides fell clearly. Available from: https://www.stat.fi/til/ksyyt/2015/ksyyt_2015_2016-12-30_kat_006_en.html [Access date: 21.08.2018]
- 2.Finnish Medicines Agency (Fimea) and Social Insurance Institution of Finland (Kela) (2016) The Finnish Statistics on Medicines, 29th edition. Available from: https://www.fimea.fi/documents/160140/1188389/Suomen_l%C3%A4%C3%A4ketilasto_2015.pdf/a813feac-1560-4cbf-80e1-44049449e0bf [Access date: 21.08.2018]
- 4.Finnish Medicines Agency (Fimea) (2013) Essitalopraami ja sitalopraami masennuksen hoidossa (in Finnish). Arviointikooste, Fimea kehittää, arvioi ja informoi -julkaisusarja 6/2013Google Scholar
- 10.Gaedigk A, Ingelman-Sundberg M, Miller NA, Leeder JS, Whirl-Carrillo M, Klein TE, the PharmVar Steering Committee (2018) The Pharmacogene Variation (PharmVar) consortium: incorporation of the human cytochrome P450 (CYP) allele nomenclature database. Clin Pharmacol Ther 103(3):399–401CrossRefGoogle Scholar
- 14.Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S (2007) CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics 17(2):93–101Google Scholar
- 17.WHO Collaborating Centre for Drug Statistics Methodology (2018) ATC classification index with DDDs. Available from: https://www.whocc.no [Access date: 21.08.2018]
- 29.RStudio Team 2016 (2016) RStudio: integrated development environment for R. Available from: www.rstudio.com [Access date: 21.08.2018]
- 32.Huezo-Diaz P, Perroud N, Spencer EP, Smith R, Sim S, Virding S, Uher R, Gunasinghe C, Gray J, Campbell D, Hauser J, Maier W, Marusic A, Rietschel M, Perez J, Giovannini C, Mors O, Mendlewicz J, McGuffin P, Farmer AE, Ingelman-Sundberg M, Craig IW, Aitchison KJ (2012) CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP. J Psychopharmacol 26(3):398–407CrossRefGoogle Scholar
- 35.Rahikainen AL, Palo JU, Haukka J, Sajantila A (2018) Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females. Pharmacogenet Genomics 28(4):99–106Google Scholar